Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

ACR Convergence 2020: COVID-19 Hyper-Inflammation in Kids

  |  Issue: December 2020  |  

Treatment
Dr. Son further discussed the ACR Clinical Guidance document and the role of IVIG, low- to moderate-dose glucocorticoids and intravenous pulse-dose glucocorticoids in the treatment of patients with MIS-C. In addition, she noted, this document also suggests anakinra can be used in cases of refractory disease.1

Dr. Son explained that many challenges still remain regarding MIS-C. For example, what is the best-case definition for this condition that clinicians around the world can agree upon? What are the biologic and genetic mechanisms that underpin this condition? What treatments should be further considered for patients with this disease? Will MIS-C become less prevalent or obsolete once an effective vaccine for SARS-CoV-2 is developed and distributed?

ADVERTISEMENT
SCROLL TO CONTINUE

As is the case for so many COVID-19 related topics this past year, many more questions than answers remain, and it will take a global effort to continue to improve the lives of children, as well as adults, facing the complications of this pandemic.

Jason Liebowitz, MD, completed his fellowship in rheumatology at Johns Hopkins University, Baltimore, where he also earned his medical degree. He is currently in practice with Skylands Medical Group, N.J.

ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Henderson LA, Canna SW, Friedman KG, et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 1. Arthritis Rheumatol. 2020 Jul 23:10.1002/art.41454.
  2. Esper F, Shapiro ED, Weibel C, et al. Association between a novel human coronavirus and Kawasaki disease. J Infect Dis. 2005 Feb 15;191(4):499–502.
  3. Goyal MK, Simpson JN, Boyle MD, et al. Racial and/or ethnic and socioeconomic disparities of SARS-CoV-2 infection among children. Pediatrics. 2020 Oct;146(4):e2020009951.
  4. Ahmed M, Advani S, Moreira A, et al. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine. 2020 Sep;26:100527.

Related Articles
    Bernard Chantal / shutterstock.com

    Diagnostic Challenges of MIS-C

    During the peak of the coronavirus pandemic in Washington, D.C., we were asked to evaluate a 14-year-old boy admitted to the pediatric hospitalist service. He had been healthy until two weeks before, when he noted a sore throat, and soon after he developed fevers and rashes without congestion, shortness of breath, conjunctivitis or swollen lymph…

    MIA Studio / shutterstock.com

    ACR Releases COVID-19 & MIS-C Clinical Guidance for Kids with Rheumatic Disease

    The ACR has released clinical guidance documents for pediatric patients with rheumatic disease in the context of the COVID-19 pandemic, including one for multi-system inflammatory syndrome in children (MIS-C). Jay Mehta, MD, MS, an attending physician in the Division of Rheumatology and director of the Pediatric Rheumatology Fellowship at the Children’s Hospital of Philadelphia (CHOP),…

    Research Helps Explain Idiosyncrasies of COVID-19

    The Basic and Clinical Research Conference session on Rheumatology Complications of Emerging Viral Infections/SARS-CoV-2 presented findings from numerous studies that help explain some of the idiosyncrasies of COVID-19.